Cardinal Health ($NYSE:CAH), Inc. is a leading healthcare services and products company that provides pharmaceutical and medical products and services to healthcare providers and payers worldwide. The increase in investment by Bellwether Advisors indicates the firm’s confidence in Cardinal Health as a long-term investment. This move is expected to add to the market capitalization of Cardinal Health and provide shareholders with increased returns from their investment.
Analysis – Cardinal Health Intrinsic Value Calculator
At GoodWhale, we recently conducted an analysis of CARDINAL HEALTH‘s wellbeing. Using our proprietary Valuation Line, we calculated the intrinsic value of CARDINAL HEALTH’s share to be around $75.2. However, the stock is currently trading at $92.2; this means the stock is currently overvalued by 22.6%. This means that investors should exercise caution when deciding whether to purchase CARDINAL HEALTH’s stock at its current level. More…
Risk Rating Analysis
Star Chart Analysis
About the Company
Ownership (Institutional/ Fund Holdings)
Below shows the total revenue, net income and net margin for Cardinal Health. More…
Income Statement Reports (Yearly/ Quarterly/ LTM)
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Cardinal Health. More…
Cash Flow Statement (Yearly/ Quarterly/ LTM)
Cash Flow Supplement
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Cardinal Health. More…
Balance Sheet (Yearly/ Quarterly)
Balance Sheet Supplement
||Book Value Per Share
Key Ratios Snapshot
Some of the financial key ratios for Cardinal Health are shown below. More…
Income Statement Ratios
Balance Sheet Ratios
Cash Flow Ratios
Other Supplementary Items
|3Y Rev Growth
||3Y Operating Profit Growth
Its competitors are AmerisourceBergen Corp, McKesson Corp, and Sigma Healthcare Ltd.
– AmerisourceBergen Corp ($NYSE:ABC)
AmerisourceBergen Corp is a drug wholesaler that was founded in 1985. The company has a market cap of 32.4B as of 2022 and a return on equity of 417.0%. AmerisourceBergen Corp distributes prescription drugs and other healthcare products and services to healthcare providers and pharmaceutical companies. The company operates in two segments, Pharmaceutical Distribution and Other.
McKesson Corp is a healthcare services and information technology company. It has a market cap of 55.96B as of 2022 and a Return on Equity of -74.43%. The company provides a range of services and products to healthcare providers, payers, and consumers. These services and products include prescription drugs, medical supplies, and software and technology solutions.
– Sigma Healthcare Ltd ($ASX:SIG)
Sigma Healthcare Ltd is a pharmaceutical company with a market cap of 683.23M as of 2022 and a ROE of 0.46%. The company manufactures and distributes a range of prescription and over-the-counter medicines, medical devices, and other healthcare products.
Cardinal Health, Inc. is a prime target for investors looking to add value to their portfolio. Analysts have noted that with its broad distribution network, low-cost structure, and strong market position, Cardinal Health is well-positioned to capitalize on favorable industry trends. However, the company is also exposed to risks such as changing customer preferences and competition. A prudent and well-thought-out investment strategy can help investors maximize returns and minimize risks.